Interim Analysis Expected End of 2Q 2025 BETHESDA, MD, Mar 14, 2025 – (ACN Newswire) – Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the […]
Read moreEmpowers Filipino entrepreneurs with expert tips, resources, and profitable business ideas. Start, grow, and succeed today!
Comments